The Medicine Maker / Issues / 2018 / Articles / Jan / In Conversation with Dago Caceres of Dow Pharmaceuticals at CPhI 2017
Manufacture Ingredients Formulation Small Molecules Small Molecules

In Conversation with Dago Caceres of Dow Pharmaceuticals at CPhI 2017

The Medicine Maker's William Aryitey met with business leaders and specialists to discuss the latest innovations and trends in pharmaceutical manufacturing. Here, William speaks with Dago Caceres from Dow Pharmaceuticals.

01/23/2018 1 min read

Share

Recommended

Related Content

The Long Road to EXCiPACT
Ingredients
The Long Road to EXCiPACT

November 7, 2014

0 min read

If I knew six years ago just how much of my time EXCiPACT would take up, would I have even started? A good question! But, actually, I have no regrets; the story of EXCiPACT and its impact, even today, on the pharmaceutical industry makes every second worthwhile...

SORS and the Power of Light in Pharma
Ingredients Analytical Science Technology and Equipment
SORS and the Power of Light in Pharma

January 17, 2025

7 min read

Understanding the role of spatially offset Raman spectroscopy in identifying raw materials, counterfeit medicines, and more

A DNA-Based Method of Anticounterfeiting
Dosage Forms Drug Delivery Formulation Ingredients
A DNA-Based Method of Anticounterfeiting

December 9, 2024

1 min read

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products

Who Are the Best Pharma Companies of 2025?
Business Practice Bioprocessing - Upstream & Downstream Contract Development Services Contract Manufacturing Services Small Molecules Ingredients
Who Are the Best Pharma Companies of 2025?

November 6, 2024

1 min read

Which companies in the pharma industry are the best? Categories in The Medicine Maker’s Company of the Year Awards include big pharma, CDMOs, equipment suppliers, and more – and we’re looking for your votes!